It could be shown that the newly developed, specific HDAC6 inhibitor “compound 6h” reduced basal cell proliferation and bronchosphere formation in 3D organoid cultures derived from airway basal cells of IPF patients. The gene discussed is HDAC6; the disease is idiopathic pulmonary fibrosis.